Hedge Fund and Insider Trading News: Bill Ackman, Morgan Creek Digital, Thryv Holdings Inc (THRY), Vor Biopharma Inc (VOR), Pool Corporation (POOL), and More

Page 2 of 2

SEC Puts Hedge Funds in Crosshairs with Stock Lending Disclosure Push (Financial News)
The Securities and Exchange Commission is moving to bring greater transparency to the securities-lending market, where short-selling hedge funds borrow shares to bet against companies’ stocks. A new rule proposed by the SEC on 18 November would require firms that lend securities to report data on each loan to an oversight body such as the Financial Industry Regulatory Authority within 15 minutes of making the loan. Data on the loans would be made public.

Thursday 11/18 Insider Buying Report: THRY, UP (Nasdaq.com)
At Thryv Holdings, a filing with the SEC revealed that on Monday, CEO and President Joe Walsh bought 45,000 shares of THRY, at a cost of $35.50 each, for a total investment of $1.6M. Walsh was up about 17.9% on the buy at the high point of today’s trading session, with THRY trading as high as $41.86 in trading on Thursday. Thryv Holdings Inc is trading up about 4.2% on the day Thursday. Before this latest buy, Walsh made one other purchase in the past twelve months, buying $3.73M shares for a cost of $18.67 a piece. And at Wheels Up Experience, there was insider buying on Tuesday, by Director David J. Adelman who bought 200,000 shares at a cost of $5.78 each, for a trade totaling $1.16M. Before this latest buy, Adelman made one other buy in the past twelve months, purchasing $754,000 shares at a cost of $7.54 a piece. Wheels Up Experience is trading down about 6.3% on the day Thursday. Bargain hunters can snag UP even cheaper than Adelman did, with the stock trading as low as $5.01 at last check today which is 13.3% below Adelman’s purchase price.

Vor Biopharma Insider Sold Over $5.0M In Company Stock (Benzinga)
Kush Parmar, Insider at Vor Biopharma (NASDAQ:VOR), made a large insider sell on November 16, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Parmar sold 330,706 shares of Vor Biopharma at a price of $15.30. The total transaction amounted to $5,059,802.

The Vice Chairman of Pool (NASDAQ: POOL) is Selling Shares (Analyst Ratings)
On November 17, the Vice Chairman of Pool (POOL), Manuel Perez De La Mesa, sold shares of POOL for $20.66M. Following Manuel Perez De La Mesa’s last POOL Sell transaction on August 16, 2021, the stock climbed by 80.4%. Based on Pool’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $1.41 billion and quarterly net profit of $185 million.

Biolife Solutions Inc (BLFS) COO & President Greef Roderick De Sold $1.1 million of Shares (Guru Focus)
COO & President of Biolife Solutions Inc, Greef Roderick De, sold 21,000 shares of BLFS on 11/18/2021 at an average price of $51.07 a share. The total sale was $1.1 million.

Page 2 of 2